We are live on
!
Find out more
WTA
Washington Trust Advisors Portfolio holdings
AUM
$1.24B
1-Year Est. Return
22.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.9%
1 Year Est. Return
+22.58%
3 Year Est. Return
+71.21%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$69.8M
(+7.2%)
Cap. Flow
-$25.5M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
37.71%
Holding
706
New
32
Increased
114
Reduced
200
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$1.68M |
| 2 |
Penumbra
PEN
|
+$647K |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$515K |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$450K |
| 5 |
Invesco NASDAQ 100 ETF
QQQM
|
+$409K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globus Medical
GMED
|
+$3.15M |
| 2 |
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
|
+$2.11M |
| 3 |
Illumina
ILMN
|
+$1.87M |
| 4 |
Brookfield Renewable
BEPC
|
+$1.6M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.07% |
| 2 | Healthcare | 15.65% |
| 3 | Industrials | 12.51% |
| 4 | Consumer Discretionary | 12.48% |
| 5 | Communication Services | 11.47% |
Similar funds
CA
MP
GX
HCA
CCA
NHAS
XF
FLII
Washington Trust Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Washington Trust Advisors held 706 positions worth $1.04B, up 7.2% from $975M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Washington Trust Advisors's Q4 2023 filing shows 32 new, 114 increased, 200 reduced and 40 closed positions. Its largest new stake was Invesco NASDAQ 100 ETF: 2,619 shares worth $441K. The largest sale was Globus Medical, an estimated $3.15M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.
- Washington Trust Advisors's largest Q4 2023 buy was Invesco NASDAQ 100 ETF: 2,619 shares worth $441K.
- Washington Trust Advisors added most to Edwards Lifesciences in Q4 2023, an estimated $1.68M increase.
- Washington Trust Advisors's biggest Q4 2023 reduction was Globus Medical, cutting an estimated $3.15M.
- Washington Trust Advisors fully exited ProShares High Yield-Interest Rate Hedged ETF in Q4 2023, selling an estimated $185K.
- Washington Trust Advisors's ten largest holdings make up 38% of its $1.04B portfolio in Q4 2023.
- Washington Trust Advisors opened 32 new positions and closed 40 in Q4 2023.
- Washington Trust Advisors's portfolio value rose 7.2% quarter-over-quarter to $1.04B.
Based on Washington Trust Advisors's 13F filing for Q4 2023, filed 18 Jan 2024.